US AAA–AA Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-09-11
https://bondscovery.com/yield-curve/usd-corporate-aaa-aa-healthcare-pharmaceuticals-callable
US AAA–AA Callable Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-09-11: 10Y at 5.41%, fitted curve 3M–40Y (4.34%–6.14%), 193 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 3M | 4.34% | — |
| 6M | 4.37% | 4.50% |
| 9M | 4.41% | 4.59% |
| 12M | 4.46% | 4.59% |
| 18M | 4.59% | 4.92% |
| 2Y | 4.72% | 5.20% |
| 3Y | 4.88% | 5.31% |
| 4Y | 5.02% | 5.53% |
| 5Y | 5.11% | 5.63% |
| 6Y | 5.18% | 5.68% |
| 7Y | 5.25% | 5.79% |
| 8Y | 5.31% | 5.92% |
| 9Y | 5.36% | 6.00% |
| 10Y | 5.41% | 6.05% |
| 15Y | 5.72% | 6.87% |
| 20Y | 5.93% | 7.29% |
| 25Y | 6.01% | 6.86% |
| 30Y | 6.05% | 6.69% |
| 40Y | 6.14% | 7.59% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.72% and the 10-year 5.41%, a 10Y−2Y spread of +69 bp — positively sloped — as of 2026-09-11. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-09-11 | 1m ago2026-08-12 | 2m ago2026-07-13 | 3m ago2026-06-12 | 4m ago2026-05-14 | 5m ago2026-04-14 | 6m ago2026-03-16 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.72% | 4.45% | 4.45% | 4.34% | 4.24% | 4.07% | 3.88% |
| 10Y | 5.41% | 5.29% | 5.16% | 5.10% | 4.96% | 4.91% | 4.81% |
| 10Y − 2Y | +69 bp | +83 bp | +71 bp | +75 bp | +72 bp | +84 bp | +93 bp |
Bonds in this curve
A selection of 30 of the 196 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche Holding AG | 4.50% | 2026-11-13 | 5.26% | US771196CE02 |
| Abbott Laboratories | 4.29% | 2026-11-30 | 3.75% | US002824BF69 |
| Roche Holding AG | 4.87% | 2027-01-28 | 2.38% | USU75000BL90 |
| ELI Lilly & CO | 4.33% | 2027-02-09 | 4.50% | US532457CJ56 |
| ELI Lilly & CO | 4.41% | 2027-05-15 | 3.10% | US532457BP26 |
| Novartis | 4.35% | 2027-05-17 | 3.10% | US66989HAN89 |
| ELI Lilly & CO | 4.48% | 2027-08-14 | 4.15% | US532457CP17 |
| Johnson & Johnson | 4.21% | 2027-09-01 | 0.95% | US478160CP78 |
| Johnson & Johnson | 4.48% | 2028-01-15 | 2.90% | US478160CK81 |
| Abbott Laboratories | 4.61% | 2028-01-30 | 1.15% | US002824BP42 |
| Sanofi SA | 4.67% | 2028-06-19 | 3.62% | US801060AD60 |
| Roche Holding AG | 4.78% | 2028-09-17 | 3.62% | USU75000BP05 |
| ELI Lilly & CO | 4.91% | 2029-03-15 | 3.38% | US532457BV93 |
| Merck & CO INC | 4.85% | 2029-03-15 | 3.85% | US58933YBW49 |
| Merck & CO INC | 5.04% | 2030-05-17 | 4.30% | US58933YBJ38 |
| Merck & CO INC | 5.02% | 2030-06-24 | 1.45% | US58933YAZ88 |
| Abbott Laboratories | 5.17% | 2031-03-15 | 4.00% | US002824BS80 |
| ELI Lilly & CO | 5.06% | 2031-03-15 | 4.25% | US532457DC94 |
| Merck & CO INC | 5.20% | 2032-09-15 | 4.55% | US58933YBR53 |
| ELI Lilly & CO | 5.20% | 2032-10-15 | 4.55% | US532457DD77 |
| Abbott Laboratories | 5.25% | 2033-03-15 | 4.30% | US002824BT63 |
| Novartis | 5.33% | 2033-03-18 | 4.60% | US66989HBH03 |
| Johnson & Johnson | 5.01% | 2034-06-01 | 4.95% | US478160CW20 |
| Merck & CO INC | 5.52% | 2035-09-15 | 4.95% | US58933YBS37 |
| Abbott Laboratories | 5.48% | 2036-03-15 | 4.65% | US002824BU37 |
| Abbott Laboratories | 5.63% | 2039-04-01 | 6.00% | US002824AV29 |
| Novartis | 5.90% | 2044-05-06 | 4.40% | US66989HAH12 |
| ELI Lilly & CO | 6.01% | 2049-03-15 | 3.95% | US532457BT48 |
| Johnson & Johnson | 5.72% | 2054-06-01 | 5.25% | US478160CX03 |
| Merck & CO INC | 6.13% | 2061-12-10 | 2.90% | US58933YBG98 |